- Home
- ZTO vs NBIX Comparison
ZTO vs NBIX Comparison
Compare ZTO & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZTO | NBIX |
|---|---|---|
| Founded | 2002 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 13.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZTO | NBIX |
|---|---|---|
| Price | $24.14 | $131.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 22 |
| Target Price | $21.90 | ★ $175.23 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 2.42% | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | N/A | ★ 4.67 |
| Revenue | N/A | ★ $161,626,000.00 |
| Revenue This Year | $11.92 | $22.57 |
| Revenue Next Year | $10.93 | $9.56 |
| P/E Ratio | ★ $21.83 | $28.00 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $16.34 | $84.23 |
| 52 Week High | $25.52 | $160.18 |
Technical Indicators
Market Signals| Indicator | ZTO | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 54.45 | 45.86 |
| Support Level | $18.23 | $122.82 |
| Resistance Level | $25.52 | $137.37 |
| Average True Range (ATR) | 0.48 | 4.02 |
| MACD | -0.08 | 0.12 |
| Stochastic Oscillator | 29.95 | 44.06 |
Price Performance
Historical ComparisonAbout ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.